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Ischemic stroke is the primary cause for sustained disabil-ity in the Western world. The initial ischemic brain damage 
leads to a robust activation of the immune system, which fol-
lows a pattern typical of sterile inflammation. Ischemic tissue 
hallmarks are the presence of IL-17 (interleukin-17)–positive 
γδ T cells, secondary neutrophil infiltration, the appearance of 
monocytes, and an upregulation of proinflammatory cytokines 
and chemokines.1–3 Even though effector functions of γδ T 
cells have been mostly decoded, the triggering inflammatory 
events are largely unclear.2,4
Recently, it has been shown that apart from their role 
in classical concepts of antigen-dependent immune 
responses,5 dendritic cells (DCs) are capable of locally 
shaping immune reactions independently of their migra-
tion to secondary lymphoid organs or antigen presen-
tation.6 Engagement of toll-like receptors on DCs by 
pathogen-associated molecular patterns or danger-asso-
ciated molecular patterns lead to the rapid production of 
cytokines, which in turn can start a fast innate-like immune 
cascade. For example, both conventional DCs (cDCs) and 
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monocyte-derived DCs can produce IL-23 (interleukin-23) 
upon stimulation with TLR5 ligands.7
In cerebral ischemia, a significant amount of CD11c+ cells 
appears early in the disease course.8,9 However, the origin, phe-
notype and function of these cells are still unknown. Because 
of the exquisite ability of DCs to mount immune responses, 
these CD11c+ cells could be of importance for the inflamma-
tory response after stroke.
The identification and classification of these cells in the brain 
is of critical importance and has been recently debated.10 In 
this study, we have used highly detailed multiparameter flow 
cytometry to identify brain-infiltrating DC subsets according 
to the classification recently proposed by Guilliams et al,11 
namely conventional type 1 DCs (cDC1s), conventional type 2 
DCs (cDC2s), and plasmacytoid DCs. We further differentiated 
cDCs and plasmacytoid DCs from monocyte-derived DCs.
Using this approach, we identified in the ischemic hemi-
sphere the presence of conventional CD172a+/IRF4+ type 2 
DCs that were the major source of IL-23, which is essential 
for the expression of IL-17 in γδ T cells.
Materials and Methods
The data that support the findings of this study are available from the 
corresponding author on reasonable request.
Animals
All animal experiments were approved by local animal care com-
mittees (Behörde für Lebensmittelsicherheit und Veterinärwesen 
Hamburg). We conducted the experiments according to the Guide 
for the Care and Use of Laboratory Animals published by the US 
National Institutes of Health (publication No. 83–123, revised 1996) 
and performed all procedures in accordance with the ARRIVE guide-
lines (Animal Research: Reporting of In Vivo Experiments; http://
www.nc3rs.org/ARRIVE). We randomized all mice and conducted 
transient middle cerebral artery occlusion (tMCAO) as described pre-
viously.2 The detailed experimental description can be found in the 
online-only Data Supplement.
Analysis of Infarct Size by TTC Staining 
and Magnetic Resonance Imaging
We analyzed infarct size by vital staining using 2% (wt/vol) TTC 
(2,3,5-triphenyl-2-hydroxy-tetrazolium chloride) in phosphate buffer. 
Magnetic resonance imaging was performed on a dedicated 7T MR 
small animal imaging system (ClinScan; Bruker). Detailed experi-
mental description can be found in the online-only Data Supplement.
Antibodies and Flow Cytometry
We performed flow cytometry for the analysis of cell types as 
described previously.2 Detailed experimental description can be 
found in the online-only Data Supplement.
Cell Sorting, RNA Isolation, and Quantitative 
Real-Time Polymerase Chain Reaction
Immune cells were sorted using a BD fluorescence-activated cell 
sorting Aria IIIu, and quantitative real-time polymerase chain reac-
tion was performed as described previously.2 Detailed experimental 
description can be found in the online-only Data Supplement.
Immunohistochemistry and Immunofluorescence
We stained mouse brains with antibodies against Ly6G (1A8; 
Biolegend), GFAP (glial fibrillary acidic protein; Dako), Iba-1 
(Wako), and laminin (1:100, Dako). Autoptic human brain sections 
were stained with antibodies against CD11c (Abcam, ab52632) and 
CD11b (Abcam, ab52478). Detailed experimental description can be 
found in the online-only Data Supplement.
Cell Transfer
We performed cell transfers as described previously.2
Bone Marrow Chimeras
Recipients were irradiated by whole-body irradiation (9 Gy) using 
a cesium-137 gamma irradiator (BIOBEAM 2000). Detailed experi-
mental description can be found in the online-only Data Supplement.
Statistical Analysis
Statistical analyses were performed using the appropriate test indicated 
in the figure legends. Briefly, we used Student t test to compare infarct 
volumes, Mann–Whitney U test for the comparison of clinical scores, 
1-way ANOVA for multiple comparisons with Bonferroni post hoc test, 
after validating the normal distribution of the data sets (Kolmogorov–
Smirnov test), and 1-way ANOVA with Bonferroni post hoc test and 
unpaired Student t test for the comparison of ΔΔCt values between 
groups. P values <0.05 were considered statistically significant.
Results
DCs Infiltrate the Brain Parenchyma Early 
and Locate to the Perilesional Area
The number of CD11c+ DCs was low in the healthy brain. 
However, after tMCAO, CD11c+ DCs had entered the ischemic 
brain and settled already at 24 hours to the peri-infarct area and, 
more specifically, close to blood vessels (Figure 1A). Next, 
we examined by immunohistochemistry postmortem stroke 
tissue from patients who had died shortly after having a stroke 
(<24 hours; Figure 1B). While we rarely observed CD11c+ 
cells in normal brain tissue, the CD11c expression increased 
in the penumbra area after stroke. The different expression 
patterns of CD11c and CD11b in postmortem stroke tissue 
indicate that the upregulation of CD11c is not only because 
of activation of CD11b+ microglia but also because of a con-
sequence of infiltrating CD11c+ immune cells. To further ana-
lyze which DC subsets infiltrate the brain in our experimental 
stroke model, we used whole-brain fluorescence-activated 
cell sorting analysis. In a first step, DCs were classified as 
CD45highCD11c+MHCII+Ly6G−, thus excluding the CD45int-
expressing microglia and the Ly6G+ neutrophils. Inside this 
population, we differentiated plasmacytoid DCs as B220+, 
cDCs as B220−Ly6C−CD64−F4/80low, and monocyte-derived 
DCs as Ly6CintF4/80intSSCintCD64int (Figure 1C).11 cDCs were 
the most prevalent DC subset at all time points. Already after 
24 hours, we observed a significant increase to 4414±3329 
cDCs per hemisphere when compared with 339±90 in sham-
operated animals. cDCs reached maximum levels at day 3 
with a subsequent decrease at day 7.
CD172a+/Irf4-Expressing cDC2 Cells 
Are the Predominant Subpopulation 
of Brain-Infiltrating cDCs
In nonlymphoid tissues, cDCs can further be differentiated 
into XCR1+/IRF8+ cDC1s and CD172a+/IRF4+ cDC2s.12 Flow 
cytometric analysis revealed that the vast majority of infiltrat-
ing cDCs was XCR1−/CD172a+ cDC2s at all investigated time 
points (Figure 2A). We also observed CD172a−/XCR1+ cDC1s, 
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which exhibited delayed infiltration kinetics. To validate that 
the XCR1−/CD172a+ cDCs found in the brain belong to the 
cDC2 subset, we relied on expression levels of C-C motif 
chemokine receptor 2 (CCR2) and ontogenetic markers. As 
reported previously,13 we also found that cDC2s had a CCR2high 
profile, whereas microglia showed significantly lower CCR2 
levels (Figure 2B). We next analyzed the expression of estab-
lished transcription factors in fluorescence-activated cell-sorted 
Figure 1. Dendritic cells (DCs) infiltrate the ischemic hemisphere and locate to the penumbra area. A, Visualization of EYFP (enhanced 
yellow fluorescent protein)-positive DCs in the penumbra of ischemic hemispheres of Cd11c-EYFP mice 1 and 3 days after transient 
middle cerebral artery occlusion (scale bars, 20 µm), and histological staining for laminin in ischemic hemispheres of CD11c-EYFP-mice 
at day 3 (scale bar, 0.7 mm). B, Immunohistochemical analysis of immune cells in ischemic human brain tissue 24 hours after stroke and 
unaffected brain tissue. Analysis was performed to detect CD11b and CD11c (scale bars, 30 µm). C, Flow cytometry of brain-infiltrating 
DC subsets. Gating strategy to identify plasmacytoid DCs (pDCs), monocyte-derived DCs (moDCs), and conventional DCs (cDCs) after 
staining for B220, CD11b, CD11c, CD45, CD64, CD172a, F4/80, Ly6C, Ly6G, MHCII, and XCR1. For absolute quantification, TrueCount 
tubes were used. C, The graphs show mean±SD of 4 to 6 animals per group, in 3 to 5 independent experiments for each time point. Sta-
tistical significances analyzed by 1-way ANOVA with Bonferroni post hoc test. **P<0.01. FSC indicates forward scatter; and SSC, side 
scatter. *cDCs vs moDCs, #cDCs vs pDCs, and moDCs vs pDCs.
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cDC2s from ischemic hemispheres at 12 and 24 hours after 
tMCAO. After normalization to corresponding levels in splenic 
cDC1s, we observed high levels for Irf4 in combination with 
low levels for Irf8 and Batf3 in CD172a+ cDC2s derived from 
ischemic brains and spleens (Figure 2C; Figures I and II in 
the online-only Data Supplement). Furthermore, the expres-
sion of the DC-specific gene Zbtb46 was maintained in cDC2s. 
Overall, high levels for Irf4, low levels for Irf8 and Batf3, 
and expression of CD172a and CCR2 are consistent with the 
established profile of cDC2s. Most importantly, microglia and 
Figure 2. Classification of infiltrating dendritic cell subsets by immunophenotyping and analysis of ontogenetic markers. A, Absolute 
numbers of XCR1+ cDC1s and CD172a+ conventional type 2 DCs (cDC2s) in ischemic hemispheres after transient middle cerebral artery 
occlusion (tMCAO). Cell counts were determined by flow cytometric analysis of central nervous system-infiltrating cells after Percoll density 
centrifugation. For absolute quantification, TrueCount tubes were used. B, Flow cytometric analysis of CCR2 level on central nervous sys-
tem-infiltrating CD172a+ cDC2s and microglia 24 hours after tMCAO. C, Relative gene expression of Irf4, Irf8, Batf3, and Zbtb46 in central 
nervous system-infiltrating and splenic CD45high/CD11b+/CD11c+/MHCII+/CD172a+/Ly6c−/Ly6g−/F4/80−/XCR1− cDC2, CD45intermed/CD11b+ 
microglia and central nervous system-infiltrating CD45high/CD11b+/CD11c−/MHCII−/Ly6g−/F4/80+ macrophages purified 24 hours after 
tMCAO by fluorescence-activated cell sorting. Expression levels were normalized to corresponding levels of splenic cDC1s. The graphs 
show mean±SEM of 5 to 8 animals per group, in 5 to 7 independent experiments for each time point. Statistical significances analyzed by 
(A) 2-way ANOVA with Bonferroni post hoc test, (B) Student t test, and (C) 1-way ANOVA with Bonferroni post hoc test. *P<0.05, **P<0.01, 
***P<0.001, ****P<0.0001. *vs cDC1 spleen, #vs cDC2 spleen, and vs cDC2 brain. MΦ indicates macrophages; and MG, microglia.
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macrophages extracted from same ischemic hemispheres dis-
played substantially different gene expression profiles. The 
results demonstrate the abundance of the newly described 
cDC2 cell population in the ischemic brain tissue.
Depletion of CD11c+ Cells in the Cd11c.DOG  
Model Is Protective in Stroke
Next, we used the Cd11c.DOG mouse model, in which a DTR 
(diphtheria toxin receptor) is expressed under the CD11c pro-
moter.14 The Cd11c.DOG model is widely used to deplete 
conventional CD11c+ DCs via injection of diphtheria toxin 
(DTX).15 To control potential toxic effects of DTX, we treated 
heterozygous Cd11c.DOG mice and littermate controls with 
DTX. Daily injections of 8 ng/g body weight DTX started 
24 hours before the tMCAO procedure14 and resulted in a 
significant reduction of splenic and brain-infiltrating DCs 
(Figure 3A and 3B). Interestingly, DTX-treated Cd11c.DOG 
mice showed significantly reduced infarct sizes, milder neu-
rological symptoms, and reduced mortality compared with 
DTX-treated littermate controls (Figure 3C and 3D).
CD11c+ Cells Induce Neutrophil 
Infiltration Into Ischemic Hemispheres 
Via Induction of IL-17 in γδ T Cells
Analysis of the immune cell infiltration in ischemic brains of 
Cd11c.DOG mice revealed significant reduction in neutrophil 
infiltration at days 1 and 3. Absolute numbers of other infil-
trating leukocyte populations were not significantly affected 
(Figure 4A and 4B; Figure IIIA in the online-only Data 
Supplement). In fact, we saw an increase in neutrophils in 
Figure 3. Depletion of CD11c+ cells in Cd11c.DOG mice is protective in a murine model of ischemic stroke. A, Depletion of CD11c+ cells 
in Cd11c.DOG mice after continuous daily administration of 8 ng/g body weight diphtheria toxin (DTX). Graph shows the percentages 
of splenic CD11c+/MHCII+ dendritic cells (DCs) of total living splenocytes in Cd11c.DOG mice compared with littermate controls 3 days 
after DTX administration. Infiltration of CD11c+/MHCII+ cells into ischemic hemispheres in Cd11c.DOG mice and littermate controls 1 day 
after transient middle cerebral artery occlusion (tMCAO). Daily administration of DTX was started 1 day before tMCAO. Cell counts were 
performed by flow cytometric analysis of splenocytes and central nervous system-infiltrating cells after staining for CD11b, CD11c, CD45, 
Ly6G, and MHCII. Graphs show the mean±SD of 9 to 12 animals per group from 3 to 4 independent experiments. B and C, Magnetic 
resonance imaging was used to quantify (representative T2 image) infarct volume at day 1 after tMCAO (left) in littermate controls and 
Cd11c.DOG mice after daily DTX administration. Neurological scores were performed 1 hour and 1 day (right) after middle cerebral artery 
occlusion (MCAO). Data are presented as mean±SD of 12 littermate controls and 16 Cd11c.DOG animals. Statistical significances ana-
lyzed by (A and B) Student t test, Mann–Whitney U test (neurological scores), and (D) χ2 test (survival rate). *P<0.05, **P<0.01.
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Figure 4. Depletion of CD11c+ cells alters the migration of neutrophils and the production of IL-17 (interleukin-17) by γδ T cells. A, 
Absolute numbers of neutrophils (n; CD45high/Ly6G+/CD11b+), macrophages (mΦ; CD45high/Ly6G−/CD11b+), microglia (m; CD45intermediate/
CD11b+), and frequency of CD4+, CD8+, γδ T cells, NK cells, and B cells in ischemic hemispheres of diphtheria toxin (DTX)-treated litter-
mate controls and Cd11c.DOG mice 1 day after middle cerebral artery occlusion (MCAO). B, Frequency of peripheral blood neutrophils 
after DTX administration in littermate controls and CD11c.DOG mice 1 day after MCAO or sham surgery, immunohistochemical staining of 
macrophages/microglia (Iba-1), astrocytes (GFAP [glial fibrillary acidic protein]), and neutrophils (Ly6G) in DTX-treated littermate controls 
and CD11c.DOG mice 1 day after MCAO (scale bar, 50 µm), and absolute numbers of neutrophils (N), macrophages (MΦ), microglia (M), 
and lymphocytes (L) 3 days after MCAO. C, Flow cytometric analysis of IL-17 (interleukin-17) and IFN-γ (interferon-γ) produced by CD4+, 
CD8+, and γδ T cells isolated from ischemic hemispheres at day 1 after stroke induction. A–C, Cell counts were determined by flow cyto-
metric analysis. D, Relative gene expression of Cxcl1 in ischemic hemispheres of DTX-treated littermate controls and Cd11c.DOG mice 
24 hours after transient middle cerebral artery occlusion (tMCAO). A–D, Daily DTX administration of 8 ng/g body weight DTX was started 
1 day before MCAO or sham surgery. Data show the mean±SD of 9 to 12 animals per group, analyzed in 3 to 4 (A–C) or 6 (D) independent 
experiments. Statistical significances were analyzed by Student t test in all cases. *P<0.05, **P<0.01. SSC indicates side scatter.
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the peripheral blood of Cd11c.DOG mice treated with DTX 
(Figure 4B), which further underscores the dysfunctional neu-
trophil migration into the brain. We and others have previously 
shown that the recruitment of neutrophils into ischemic hemi-
spheres depends on the IL-17A production by γδ T cells, which 
in turn induces C-X-C motif chemokine ligand 1 production 
by astrocytes.2 After depletion of CD11c+ cells, we observed 
a significant decrease of IL-17 levels in brain-infiltrating γδ T 
cells on days 1 and 3, which was paralleled by increased IFN-γ 
(interferon-γ) levels in γδ T cells on day 3 (Figure 4C; Figure 
IIIB in the online-only Data Supplement), whereas cytokine 
levels in infiltrating αβ T cells were not altered. Consistent 
with the reduction in IL-17, we detected significantly decreased 
Cxcl1 levels in DTX-treated Cd11c.DOG mice (Figure 4D).
Infiltrating IL-17+ γδ T Cells Express the IL-23R
A potential regulator of IL-17 production in T cells is IL-23.16 
To address the role of IL-23 in stroke, we analyzed a knock-in 
reporter mouse, in which an IRES GFP (internal ribosomal 
entry site green fluorescent protein) cassette was introduced in 
the endogenous IL-23R (IL-23 receptor) gene locus.17 In het-
erozygous mice, IL-23R–expressing cells can be visualized 
by their GFP expression (Il23r.gfp.KI). When bred as homo-
zygotes (Il23r−/−), the deletion of the IL-23R abrogates their 
responsiveness to IL-23. In our model, 3 days after tMCAO, 
we observed that ≈80% of the brain-infiltrating IL-17A+ γδ T 
cells coexpressed the IL-23R (Figure 5A).
Il23r−/− Mice Have a Defective IL-17 Response in γδ 
T Cells and Are Protected From Ischemic Stroke
Neutrophil infiltration, frequency of IL-17–producing γδ T 
cells, Cxcl1 expression, and infarct sizes were significantly 
decreased in Il23r−/− mice after tMCAO (Figure 5A through 
5C). In contrast, infiltration of macrophages, DCs and T-cell 
subpopulations, expansion of microglia, IFN-γ production in 
αβ T cells, and mortality rate were not affected by the IL-23R 
deficiency (Figure 5A and 5B; Figure IVB and IVC in the 
online-only Data Supplement). To underline the importance 
of the IL-23R on T cells, we transferred unfractionated T cells 
from Il23r+/+ or Il23r−/− mice to T cell–deficient mice (Rag1−/− 
mice). Three days after stroke, neutrophil infiltration into isch-
emic hemispheres was significantly reduced after transfer of 
Il23r−/− T cells compared with Il23r+/+ T cells (Figure 5D).
IL-23 Is Rapidly Induced in Brain-
Infiltrating cDC2 Cells
To test whether cDC2s released IL-23, we measured levels of 
Il23p19 and Tnf transcripts in cDC2s, macrophages, and microg-
lia, sorted from ischemic hemispheres and in splenic cDC2s by 
quantitative real-time polymerase chain reaction (gating strategy 
in Figure I in the online-only Data Supplement). After normaliza-
tion to levels in microglia, we found that Il23p19 transcripts were 
significantly upregulated in cDC2s in comparison with infiltrat-
ing macrophages and resident microglia at 24 hours, whereas 
Tnf levels were reduced in cDC2s (Figure 6A). Comparing the 
Il23p19 levels from brain-derived cDC2s with splenic cDC2s, we 
found a 70-fold increase in cDC2s derived from ischemic hemi-
spheres (Figure 6B). In congruence, we found reduced expression 
levels of Il23p19 transcripts in ischemic hemispheres of CD11c.
DOG mice after depletion of CD11c+ cells (Figure 6C). To con-
firm that infiltrating cDC2s and not microglia are the main source 
of IL-23, we generated bone marrow chimeric mice. Wild-type 
animals reconstituted with Il23p19−/− bone marrow showed a 
significantly reduced neutrophil infiltration into ischemic hemi-
spheres (Figure 6D), underscoring the essential expression of 
IL-23 in peripheral immune cells.
Discussion
In this study, we identify IRF4+/CD172a+ DCs (cDC2s) as the 
predominant DC subset in the ischemic brain, and major source of 
IL-23, which in turn promotes IL-17 production in γδ T cells and 
the subsequent recruitment of neutrophils to the ischemic hemi-
sphere. Thus, cDC2s orchestrate the early phase of poststroke 
inflammation. Disruption of the IL-23–IL-17 pathway, either by 
depletion of CD11c+ cells or by genetic ablation of the IL-23R, 
resulted in a significantly reduced frequency of IL-17–producing 
γδ T cells in ischemic brains and improved the neurological out-
come after stroke. Moreover, our analysis of human pathological 
tissue revealed that DCs are present in human stroke tissue.
DCs had already been described as part of the infiltrat-
ing immune cells in stroke, but their phenotype and immu-
nologic function remained elusive. These CD11c+ cells were 
primarily described as CD45high/CD11b+/CD8α− and located 
both in direct proximity of the stroke but also in remote 
areas.8 According to the new DC nomenclature proposed by 
Guilliams et al,11 we can now classify the infiltrating DCs in 
stroke based on their phenotype, function, and lineage-spe-
cific transcription markers. Applying this classification, we 
found that CD172a+ cDC2s were the predominant subpopu-
lation already at 24 hours after stroke, outnumbering mono-
cyte-derived DCs, plasmacytoid DCs, and cDC1s. We further 
confirmed the identity of the cDC2s based on high expres-
sion levels of the developmental transcription factors Irf4 and 
Zbtb46 in combination with low levels of Irf8 and Batf3.18,19
The observation of an early protection from ischemic stroke 
after depletion of CD11c+ cells is in line with a central role 
of these rapidly infiltrating cDC2s in the initiation of sterile 
inflammation. We found that the cDC2s served as an essen-
tial early source of IL-23. The subsequent IL-23–dependent 
immune response is similar to the initiation of inflammation 
during infection.20 In short, IL-23 drives and sustains IL-17 
production in γδ T cells, which in turn triggers mechanisms for 
neutrophil recruitment. γδ T cells are lymphocytes, which can 
be rapidly activated in a T cell receptor-independent manner. 
Interestingly, others and we have shown that a specific sub-
population of γδ T cells, so called natural IL-17–producing γδ 
T cells, is responsible for the rapid IL-17 production in mod-
els of stroke, infection, and autoimmunity.20,21 These IL-17+ γδ 
T cells also carry the IL-23R and, therefore, can be activated 
by IL-23.20 In other organ systems, Irf4-expressing cDC2 cells 
are also specialized in driving IL-17 responses. These cells 
are known to induce IL-17 responses in the lung and the intes-
tine.22 However, our finding that the depletion of CD11c+ cells 
improved survival, whereas the genetic ablation of the IL-23R 
did not reveal significant effects on mortality, indicates that 
CD11c+ cells exert their detrimental function not only through 
IL-23 but also other mechanisms.
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Figure 5. Disruption of IL-23 (interleukin-23) signaling is protective in ischemic stroke. A, Flow cytometric analysis of the IL-23R (IL-23 recep-
tor) expression in IL-17+ and IL-17− γδ T-cell subsets isolated from ischemic hemispheres of Il23r.gfp.KI mice, and flow cytometric analysis 
of absolute numbers of neutrophils (N), macrophages (MΦ), dendritic cells (DC), lymphocytes (L), and microglia (M) isolated from ischemic 
hemispheres of littermate controls and Il23r−/− mice 3 days after transient middle cerebral artery occlusion (tMCAO). Lymphocytes from Il23r.
gfp.KI mice were stained for CD45, CD3, NK1.1, and γδ T cell receptor followed by an intracellular staining for IL-17. Histograms show expres-
sion of IL-23R in IL-17–positive and negative γδ T cells of 1 representative experiment at day 3. central nervous system-infiltrating cells were 
stained for CD45, Ly6G, CD11b, CD11b, MHCII, B220, CD3, NK1.1, CD4, CD8, and γδ T cell receptor. B, Frequency of CD4+, CD8+, and γδ 
T cells, flow cytometric analysis of IL-17 produced by CD4+, CD8+, and γδ T cells isolated from ischemic hemispheres of littermate controls 
and Il23r−/− mice 3 days after tMCAO, and relative gene expression of Cxcl1 in ischemic hemispheres of littermate controls and Il23r−/− mice 24 
hours after tMCAO. C, Triphenyltetrazolium chloride (TTC) staining for evaluation of infarct volume at day 3 (left), and neurological scores at 
days 1 and 3 (right) of littermate controls and Il23r−/− mice after middle cerebral artery occlusion (MCAO). Data are presented as mean±SD of 8 
littermate controls and 8 Il23r−/− animals. D, Percentage of neutrophils in central nervous system-infiltrating cells of Rag1−/− mice reconstituted 
1 hour before stroke induction with 1×107 CD3+ cells isolated from wild-type (WT) or Il23r−/− mice. A, B, and D, Data show the mean±SD of 4 to 
8 animals per group, analyzed in 3 to 4 independent experiments. Statistical significances were analyzed by Student t test (A–D) and Mann–
Whitney U test for neurological scores (C). *P<0.05, **P<0.01, ***P<0.001. FSC indicates forward scatter; SSC, side scatter.
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Figure 6. IL-23 (interleukin-23) is rapidly induced in brain-infiltrating conventional type 2 DCs (cDC2) cells. A, Relative gene expression of 
Il23 and Tnf in infiltrating cDC2s (CD45high/CD11b+/CD11c+/MHCII+/CD172a+/Ly6c−/Ly6g−/F4/80−/XCR1−) and macrophages/monocytes 
(CD45high/CD11b+/F4/80+/CD11c−/Ly6g−) purified from ischemic hemispheres 12 and 24 hours after middle cerebral artery occlusion (MCAO) 
by fluorescence-activated cell sorting. Expression levels were normalized to corresponding levels in (A) microglia (CD45intermediate/CD11b+) or 
(B) splenic cDC2s. The graphs show the mean±SD of 6 to 8 independent experiments for each time point. C, Relative gene expression of 
Il23 in the stroked hemispheres of diphtheria toxin (DTX)-treated CD11c.DOG mice and littermate controls 24 hours after transient middle 
cerebral artery occlusion. Daily administration of DTX was started 1 day before MCAO (n=6 mice). D, Frequency of neutrophils in ischemic 
hemispheres of bone marrow chimeras at day 1 after MCAO (n=6 mice). Statistical significances were analyzed by (A) 1-way ANOVA with 
Bonferroni post hoc test and (B–D) Student t test. *P<0.05, **P<0.01, ***P<0.001. MΦ indicates macrophages; and MG, microglia.
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Previously, infiltrating macrophages were believed to be 
the main source of IL-23 in stroke.4 This apparent discrepancy 
can be explained by the gating strategy applied for the fluo-
rescence-activated cell sorting of macrophages and microglia 
in previous studies.4 Macrophages were identified by gating 
on CD45high/CD11b+ cells—a strategy that included IL-23–
producing cDC2s. Furthermore, based on our chimera experi-
ments, we can now attribute the IL-23/IL-17–mediated effects 
to radiation-sensitive peripheral immune cells.
Throughout the study, we focused on the role of cDC2s 
because of their rapid infiltration kinetics and significantly 
increased abundance in comparison with all other DC subsets. 
Nevertheless, we also observed cDC1s with delayed infiltra-
tion kinetics. Even though the immunologic function of the 
cDC1 cells is unclear, a regulatory role for XCR1+/CD172a– 
cDC1s can be speculated. Recent experimental data suggest 
that CD103+ DCs from the small intestine can shape the IL-17 
response in T cells. In a model of experimental stroke, altera-
tions of the intestinal flora led to a decrease in IL-17–positive 
γδ T cells in the ischemic brain. These changes could be traced 
back to an increase of CD103+ DCs in the gut. The CD103+ 
are likely to belong to the cDC1 subset, which we found in 
ischemic hemisphere at later stages.23
In conclusion, our study provides further insights into the 
inflammatory cytokine and immune cell networks of post-
stroke inflammation and suggests that rapidly infiltrating 
IRF4+/CD172a+ cDC2s are an essential source of IL-23. These 
findings indicate that cDC2s are critical for the initiation of the 
detrimental IL-17–driven innate immune response in stroke.
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